Pharmaceutical Incursion on Cigarette Smoking at the Birth of the Brain Disease Model of Addiction

Abstract

Purpose – With reference to the long-term struggle to confirm cigarette smoking as a manifestation of nicotine addiction, this chapter explores the extent to which new understandings of addictions as ‘appetitive disorders’ rather than ‘dependence disorders’ derive from treatment technology development as well as advances in basic scientific research.

Approach – Through historical analysis it is discussed how cigarette smoking only became widely accepted as a real drug problem in the 1980s after it had been shown to be amenable to treatment as such through the use of novel nicotine replacement therapies.

Findings – These replacement therapies succeeded in showing that the same drug that drew users into addiction could be redeployed to help draw up them out of it. Nicorette® could serve as at least the partial antidote to nico-wrong (cigarettes). However, as relapse to smoking has remained the most likely outcome of any smoking cessation attempt, so medicinal nicotine has also served to demonstrate that nicotine addiction is ultimately a problem of an uncontrollable appetite for cigarettes in excess of drug dependence.

Implications – Pharmaceutical incursion on cigarette smoking commencing in the late 1970s pointed to the need for a new mental disease model of drug-related problems while also providing valuable new tools and insights for ensuing brain research.

Citation

Elam, M. (2012), "Pharmaceutical Incursion on Cigarette Smoking at the Birth of the Brain Disease Model of Addiction", Netherland, J. (Ed.) Critical Perspectives on Addiction (Advances in Medical Sociology, Vol. 14), Emerald Group Publishing Limited, Leeds, pp. 53-75. https://doi.org/10.1108/S1057-6290(2012)0000014007